메뉴 건너뛰기




Volumn 10, Issue 3, 2010, Pages 193-198

European vs. Egyptian HCV-4 patients with elevated baseline HCV RNA, treated with PEG-IFN-α2a and Ribavirin: The role of rapid and early virologic response

Author keywords

EVR; Genotype 4; HCV; RVR; Treatment

Indexed keywords

ALANINE AMINOTRANSFERASE; GAMMA GLUTAMYLTRANSFERASE; HEMOGLOBIN; MIRTAZAPINE; PEGINTERFERON ALPHA2A; RIBAVIRIN; VIRUS RNA;

EID: 77954872107     PISSN: 1735143X     EISSN: 17353408     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (8)

References (29)
  • 1
    • 18344381087 scopus 로고    scopus 로고
    • Chronic hepatitis C and genotyping: The clinical significance of determining HCV genotypes
    • Hnatyszyn HJ. Chronic hepatitis C and genotyping: the clinical significance of determining HCV genotypes. Antivir Ther. 2005;10(1):1-11.
    • (2005) Antivir Ther , vol.10 , Issue.1 , pp. 1-11
    • Hnatyszyn, H.J.1
  • 2
    • 76149141825 scopus 로고    scopus 로고
    • Hepatitis C virus: Molecular biology & current therapeutic options
    • Sharma SD. Hepatitis C virus: molecular biology & current therapeutic options. Indian J Med Res. 2010;131:17-34.
    • (2010) Indian J Med Res , vol.131 , pp. 17-34
    • Sharma, S.D.1
  • 3
    • 26444432835 scopus 로고    scopus 로고
    • Prevalence and treatment of hepatitis C virus genotypes 4, 5, and 6
    • Nguyen MH, Keeffe EB. Prevalence and treatment of hepatitis C virus genotypes 4, 5, and 6. Clin Gastroenterol Hepatol. 2005;3(10 Suppl 2):S97-S101.
    • (2005) Clin Gastroenterol Hepatol , vol.3 , Issue.10 SUPPL 2
    • Nguyen, M.H.1    Keeffe, E.B.2
  • 4
    • 42249110672 scopus 로고    scopus 로고
    • Hepatitis C genotype 4: What we know and what we don't yet know
    • Kamal SM, Nasser IA. Hepatitis C genotype 4: What we know and what we don't yet know. Hepatology. 2008;47(4):1371- 83.
    • (2008) Hepatology , vol.47 , Issue.4 , pp. 1371-1383
    • Kamal, S.M.1    Nasser, I.A.2
  • 5
    • 21844457406 scopus 로고    scopus 로고
    • Changing of hepatitis C virus genotype patterns in France at the beginning of the third millenium: The GEMHEP GenoCII Study
    • Payan C, Roudot-Thoraval F, Marcellin P, et al. Changing of hepatitis C virus genotype patterns in France at the beginning of the third millenium: The GEMHEP GenoCII Study. J Viral Hepat. 2005;12(4):405-13.
    • (2005) J Viral Hepat , vol.12 , Issue.4 , pp. 405-413
    • Payan, C.1    Roudot-Thoraval, F.2    Marcellin, P.3
  • 6
    • 11444267247 scopus 로고    scopus 로고
    • Heterogeneity of hepatitis C virus genotype 4 strains circulating in south-western France
    • Nicot F, Legrand-Abravanel F, Sandres-Saune K, et al. Heterogeneity of hepatitis C virus genotype 4 strains circulating in south-western France. J Gen Virol. 2005;86(Pt 1):107-14.
    • (2005) J Gen Virol , vol.86 , Issue.PT 1 , pp. 107-114
    • Nicot, F.1    Legrand-Abravanel, F.2    Sandres-Saune, K.3
  • 7
    • 33644875745 scopus 로고    scopus 로고
    • Molecular epidemiology of hepatitis C virus (HCV) in Greece: Temporal trends in HCV genotype-specific incidence and molecular characterization of genotype 4 isolates
    • Katsoulidou A, Sypsa V, Tassopoulos NC, et al. Molecular epidemiology of hepatitis C virus (HCV) in Greece: temporal trends in HCV genotype-specific incidence and molecular characterization of genotype 4 isolates. J Viral Hepat. 2006;13(1):19-27.
    • (2006) J Viral Hepat , vol.13 , Issue.1 , pp. 19-27
    • Katsoulidou, A.1    Sypsa, V.2    Tassopoulos, N.C.3
  • 8
    • 33749583068 scopus 로고    scopus 로고
    • High prevalence of hepatitis C virus subtypes 4c and 4d in Malaga (Spain): Phylogenetic and epidemiological analyses
    • Fernandez-Arcas N, Lopez-Siles J, Trapero S, et al. High prevalence of hepatitis C virus subtypes 4c and 4d in Malaga (Spain): phylogenetic and epidemiological analyses. J Med Virol. 2006;78(11):1429-35.
    • (2006) J Med Virol , vol.78 , Issue.11 , pp. 1429-1435
    • Fernandez-Arcas, N.1    Lopez-Siles, J.2    Trapero, S.3
  • 9
    • 1842555459 scopus 로고    scopus 로고
    • Kinetics of intrahepatic hepatitis C virus (HCV)-specific CD4+ T cell responses in HCV and Schistosoma mansoni coinfection: Relation to progression of liver fibrosis
    • Kamal SM, Graham CS, He Q, et al. Kinetics of intrahepatic hepatitis C virus (HCV)-specific CD4+ T cell responses in HCV and Schistosoma mansoni coinfection: relation to progression of liver fibrosis. J Infect Dis. 2004;189(7):1140-50.
    • (2004) J Infect Dis , vol.189 , Issue.7 , pp. 1140-1150
    • Kamal, S.M.1    Graham, C.S.2    He, Q.3
  • 10
    • 33645986652 scopus 로고    scopus 로고
    • Progression of fibrosis in hepatitis C with and without schistosomiasis: Correlation with serum markers of fibrosis
    • Kamal SM, Turner B, He Q, et al. Progression of fibrosis in hepatitis C with and without schistosomiasis: correlation with serum markers of fibrosis. Hepatology. 2006;43(4):771-9.
    • (2006) Hepatology , vol.43 , Issue.4 , pp. 771-779
    • Kamal, S.M.1    Turner, B.2    He, Q.3
  • 11
    • 34250625319 scopus 로고    scopus 로고
    • Epidemiological characteristics and response to peginterferon plus ribavirin treatment of hepatitis C virus genotype 4 infection
    • Roulot D, Bourcier V, Grando V, et al. Epidemiological characteristics and response to peginterferon plus ribavirin treatment of hepatitis C virus genotype 4 infection. J Viral Hepat. 2007;14(7):460-7.
    • (2007) J Viral Hepat , vol.14 , Issue.7 , pp. 460-467
    • Roulot, D.1    Bourcier, V.2    Grando, V.3
  • 12
    • 0033930712 scopus 로고    scopus 로고
    • Improved response to ribavirin interferon combination compared with interferon alone in patients with type 4 chronic hepatitis C without cirrhosis
    • Koshy A, Marcellin P, Martinot M, Madda JP. Improved response to ribavirin interferon combination compared with interferon alone in patients with type 4 chronic hepatitis C without cirrhosis. Liver. 2000;20(4):335-9.
    • (2000) Liver , vol.20 , Issue.4 , pp. 335-339
    • Koshy, A.1    Marcellin, P.2    Martinot, M.3    Madda, J.P.4
  • 13
    • 0034674034 scopus 로고    scopus 로고
    • Infection with hepatitis C virus genotype 4 is associated with a poor response to interferon-alpha
    • Zylberberg H, Chaix ML, Brechot C. Infection with hepatitis C virus genotype 4 is associated with a poor response to interferon-alpha. Ann Intern Med. 2000;132(10):845-6.
    • (2000) Ann Intern Med , vol.132 , Issue.10 , pp. 845-846
    • Zylberberg, H.1    Chaix, M.L.2    Brechot, C.3
  • 14
    • 0033962163 scopus 로고    scopus 로고
    • Interferon therapy in patients with chronic hepatitis C and schistosomiasis
    • Kamal SM, Madwar MA, Peters T, Fawzy R, Rasenack J. Interferon therapy in patients with chronic hepatitis C and schistosomiasis. J Hepatol. 2000;32(1):172-4.
    • (2000) J Hepatol , vol.32 , Issue.1 , pp. 172-174
    • Kamal, S.M.1    Madwar, M.A.2    Peters, T.3    Fawzy, R.4    Rasenack, J.5
  • 15
    • 21144449073 scopus 로고    scopus 로고
    • Peginterferon {alpha}-2b and ribavirin therapy in chronic hepatitis C genotype 4: Impact of treatment duration and viral kinetics on sustained virological response
    • Kamal SM, El Tawil AA, Nakano T, et al. Peginterferon {alpha}-2b and ribavirin therapy in chronic hepatitis C genotype 4: impact of treatment duration and viral kinetics on sustained virological response. Gut. 2005;54(6):858-66.
    • (2005) Gut , vol.54 , Issue.6 , pp. 858-866
    • Kamal, S.M.1    El Tawil, A.A.2    Nakano, T.3
  • 16
    • 4544344295 scopus 로고    scopus 로고
    • Peginterferon alfa- 2b plus ribavirin for the treatment of chronic hepatitis C genotype 4
    • Hasan F, Asker H, Al-Khaldi J, et al. Peginterferon alfa- 2b plus ribavirin for the treatment of chronic hepatitis C genotype 4. Am J Gastroenterol. 2004;99(9):1733-7.
    • (2004) Am J Gastroenterol , vol.99 , Issue.9 , pp. 1733-1737
    • Hasan, F.1    Asker, H.2    Al-Khaldi, J.3
  • 17
    • 19944409281 scopus 로고    scopus 로고
    • Peginterferon alpha-2b plus ribavirin compared with interferon alpha-2b plus ribavirin for initial treatment of chronic hepatitis C in Saudi patients commonly infected with genotype 4
    • Alfaleh FZ, Hadad Q, Khuroo MS, et al. Peginterferon alpha-2b plus ribavirin compared with interferon alpha-2b plus ribavirin for initial treatment of chronic hepatitis C in Saudi patients commonly infected with genotype 4. Liver Int. 2004;24(6):568-74.
    • (2004) Liver Int , vol.24 , Issue.6 , pp. 568-574
    • Alfaleh, F.Z.1    Hadad, Q.2    Khuroo, M.S.3
  • 18
    • 32444449114 scopus 로고    scopus 로고
    • Response of hepatitis C genotype-4 naive patients to 24 weeks of Peginterferon- alpha2b/ribavirin or induction-dose interferonalpha2b/ribavirin/amantadine: A non-randomized controlled study
    • El-Zayadi AR, Attia M, Barakat EM, et al. Response of hepatitis C genotype-4 naive patients to 24 weeks of Peginterferon- alpha2b/ribavirin or induction-dose interferonalpha2b/ribavirin/amantadine: a non-randomized controlled study. Am J Gastroenterol. 2005;100(11):2447-52.
    • (2005) Am J Gastroenterol , vol.100 , Issue.11 , pp. 2447-2452
    • El-Zayadi, A.R.1    Attia, M.2    Barakat, E.M.3
  • 19
    • 37749046123 scopus 로고    scopus 로고
    • Pegylated interferon alpha-2b plus ribavirin in patients with genotype 4 chronic hepatitis C: The role of rapid and early virologic response
    • Kamal SM, El Kamary SS, Shardell MD, et al. Pegylated interferon alpha-2b plus ribavirin in patients with genotype 4 chronic hepatitis C: The role of rapid and early virologic response. Hepatology. 2007;46(6):1732-40.
    • (2007) Hepatology , vol.46 , Issue.6 , pp. 1732-1740
    • Kamal, S.M.1    El Kamary, S.S.2    Shardell, M.D.3
  • 20
    • 33750100192 scopus 로고    scopus 로고
    • Treatment of hepatitis C virus genotype 4 with peginterferon alfa- 2a: Impact of bilharziasis and fibrosis stage
    • Derbala MF, Al Kaabi SR, El Dweik NZ, et al. Treatment of hepatitis C virus genotype 4 with peginterferon alfa- 2a: impact of bilharziasis and fibrosis stage. World J Gastroenterol. 2006;12(35):5692-8.
    • (2006) World J Gastroenterol , vol.12 , Issue.35 , pp. 5692-5698
    • Derbala, M.F.1    Al Kaabi, S.R.2    El Dweik, N.Z.3
  • 21
    • 0346727453 scopus 로고    scopus 로고
    • Optimized virologic response in hepatitis C virus genotype 4 with peginterferon-alpha2a and ribavirin
    • Diago M, Hassanein T, Rodes J, Ackrill AM, Sedarati F. Optimized virologic response in hepatitis C virus genotype 4 with peginterferon-alpha2a and ribavirin. Ann Intern Med. 2004;140(1):72-3.
    • (2004) Ann Intern Med , vol.140 , Issue.1 , pp. 72-73
    • Diago, M.1    Hassanein, T.2    Rodes, J.3    Ackrill, A.M.4    Sedarati, F.5
  • 22
    • 34547738021 scopus 로고    scopus 로고
    • Clinical and pathological characteristics and response to combination therapy of genotype 4 chronic hepatitis C patients: Experience from a spanish center
    • Trapero-Marugan M, Moreno-Monteagudo JA, Garcia- Buey L, et al. Clinical and pathological characteristics and response to combination therapy of genotype 4 chronic hepatitis C patients: experience from a spanish center. J Chemother. 2007;19(4):423-7.
    • (2007) J Chemother , vol.19 , Issue.4 , pp. 423-427
    • Trapero-Marugan, M.1    Moreno-Monteagudo, J.A.2    Garcia-Buey, L.3
  • 23
    • 23044510877 scopus 로고    scopus 로고
    • Pegylated interferon and ribavirin therapy for chronic hepatitis C virus genotype 4 infection
    • Legrand-Abravanel F, Nicot F, Boulestin A, et al. Pegylated interferon and ribavirin therapy for chronic hepatitis C virus genotype 4 infection. J Med Virol. 2005;77(1):66-9.
    • (2005) J Med Virol , vol.77 , Issue.1 , pp. 66-69
    • Legrand-Abravanel, F.1    Nicot, F.2    Boulestin, A.3
  • 24
    • 18344364551 scopus 로고    scopus 로고
    • Response to interferon-based therapies in HIV-infected patients with chronic hepatitis C due to genotype 4
    • Soriano V, Nunez M, Sanchez-Conde M, et al. Response to interferon-based therapies in HIV-infected patients with chronic hepatitis C due to genotype 4. Antivir Ther. 2005;10(1):167-70.
    • (2005) Antivir Ther , vol.10 , Issue.1 , pp. 167-170
    • Soriano, V.1    Nunez, M.2    Sanchez-Conde, M.3
  • 25
    • 48749099989 scopus 로고    scopus 로고
    • Peginterferon alfa- 2a and ribavirin for 24 weeks in hepatitis C type 1 and 4 patients with rapid virological response
    • Ferenci P, Laferl H, Scherzer TM, et al. Peginterferon alfa- 2a and ribavirin for 24 weeks in hepatitis C type 1 and 4 patients with rapid virological response. Gastroenterology. 2008;135(2):451-8.
    • (2008) Gastroenterology , vol.135 , Issue.2 , pp. 451-458
    • Ferenci, P.1    Laferl, H.2    Scherzer, T.M.3
  • 26
    • 70349234307 scopus 로고    scopus 로고
    • Differential viral kinetics in treated genotype 4 chronic hepatitis C patients according to ethnicity
    • Elefsiniotis IS, Pavlidis C, Dimitroulopoulos D, et al. Differential viral kinetics in treated genotype 4 chronic hepatitis C patients according to ethnicity. J Viral Hepat. 2009;16(10):738-42.
    • (2009) J Viral Hepat , vol.16 , Issue.10 , pp. 738-742
    • Elefsiniotis, I.S.1    Pavlidis, C.2    Dimitroulopoulos, D.3
  • 27
    • 77950624760 scopus 로고    scopus 로고
    • The neglected hepatitis C virus genotypes 4, 5 and 6: An international consensus report
    • Antaki N, Craxi A, Kamal S, et al. The neglected hepatitis C virus genotypes 4, 5 and 6: an international consensus report. Liver Int. 2010;30(3):342-55.
    • (2010) Liver Int , vol.30 , Issue.3 , pp. 342-355
    • Antaki, N.1    Craxi, A.2    Kamal, S.3
  • 28
    • 85061109161 scopus 로고    scopus 로고
    • MxA expression as marker for assessing the therapeutic response in HCV genotype 4 Egyptian patients
    • Shaker O, Ahmed A, Doss W, Abdel-Hamid M. MxA expression as marker for assessing the therapeutic response in HCV genotype 4 Egyptian patients. J Viral Hepat. 2009.
    • (2009) J Viral Hepat
    • Shaker, O.1    Ahmed, A.2    Doss, W.3    Abdel-Hamid, M.4
  • 29
    • 33847379731 scopus 로고    scopus 로고
    • Genetic distance and heterogenecity between quasispecies is a critical predictor to IFN response in Egyptian patients with HCV genotype-4
    • Zekri AR, El-Din HM, Bahnassy AA, et al. Genetic distance and heterogenecity between quasispecies is a critical predictor to IFN response in Egyptian patients with HCV genotype-4. Virol J. 2007;4:16.
    • (2007) Virol J , vol.4 , pp. 16
    • Zekri, A.R.1    El-Din, H.M.2    Bahnassy, A.A.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.